UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules

Molecules (Basel, Switzerland), 2019-02, Vol.24 (4), p.809

2019

Volltextzugriff (PDF)

The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules

Molecules (Basel, Switzerland), 2023-01, Vol.28 (3), p.1038

2023

Volltextzugriff (PDF)

The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules

Molecules (Basel, Switzerland), 2020-02, Vol.25 (3), p.745

2020

Volltextzugriff (PDF)

The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules

Molecules (Basel, Switzerland), 2022-02, Vol.27 (3), p.1075

2022

Volltextzugriff (PDF)

Peptide Therapeutics 2.0

Molecules (Basel, Switzerland), 2020-05, Vol.25 (10), p.2293

2020

Volltextzugriff (PDF)

Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate

Pharmaceutics, 2022-02, Vol.14 (2), p.396

2022

Volltextzugriff (PDF)

The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules

Molecules (Basel, Switzerland), 2024-01, Vol.29 (3), p.585

2024

Volltextzugriff (PDF)

Breaking a Couple: Disulfide Reducing Agents

Chembiochem : a European journal of chemical biology, 2020-07, Vol.21 (14), p.1947-1954

2020

Volltextzugriff (PDF)

The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules

Molecules (Basel, Switzerland), 2018-02, Vol.23 (3), p.533

2018

Volltextzugriff (PDF)

The challenge of peptide nucleic acid synthesis

Chemical Society reviews, 2023-04, Vol.52 (8), p.2764-2789

2023

Volltextzugriff (PDF)

2021 FDA TIDES (Peptides and Oligonucleotides) Harvest

Pharmaceuticals (Basel, Switzerland), 2022-02, Vol.15 (2), p.222

2022

Volltextzugriff (PDF)

Safety-Catch Linkers for Solid-Phase Peptide Synthesis

Molecules (Basel, Switzerland), 2024-04, Vol.29 (7), p.1429

2024

Volltextzugriff (PDF)

Naturally Occurring Oxazole-Containing Peptides

Marine drugs, 2020-04, Vol.18 (4), p.203

2020

Volltextzugriff (PDF)

2022 FDA TIDES (Peptides and Oligonucleotides) Harvest

Pharmaceuticals (Basel, Switzerland), 2023-02, Vol.16 (3), p.336

2023

Volltextzugriff (PDF)

2023 FDA TIDES (Peptides and Oligonucleotides) Harvest

Pharmaceuticals (Basel, Switzerland), 2024-02, Vol.17 (2), p.243

2024

Volltextzugriff (PDF)

The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules

Molecules (Basel, Switzerland), 2021-01, Vol.26 (3), p.627

2021

Volltextzugriff (PDF)

Scope and Limitations of γ-Valerolactone (GVL) as a Green Solvent to be Used with Base for Fmoc Removal in Solid Phase Peptide Synthesis

Molecules (Basel, Switzerland), 2019-11, Vol.24 (21), p.4004

2019

Volltextzugriff (PDF)

Serinol-Based Versatile Disulfide-Reducing Reagent

Molecules (Basel, Switzerland), 2023-07, Vol.28 (14), p.5489

2023

Volltextzugriff (PDF)

2018 FDA Tides Harvest

Pharmaceuticals (Basel, Switzerland), 2019-04, Vol.12 (2), p.52

2019

Volltextzugriff (PDF)

2017 FDA Peptide Harvest

Pharmaceuticals (Basel, Switzerland), 2018-05, Vol.11 (2), p.42

2018

Volltextzugriff (PDF)

1,3,5-Triazine as Branching Connector for the Construction of Novel Antimicrobial Peptide Dendrimers: Synthesis and Biological Characterization

International journal of molecular sciences, 2024-06, Vol.25 (11), p.5883

2024

Volltextzugriff (PDF)

Greening Fmoc/tBu solid-phase peptide synthesis

Green chemistry : an international journal and green chemistry resource : GC, 2020-01, Vol.22 (4), p.996-1018

2020

Volltextzugriff (PDF)

Synthesis and Antimicrobial Activity of a New Series of Thiazolidine-2,4-diones Carboxamide and Amino Acid Derivatives

Molecules (Basel, Switzerland), 2019-12, Vol.25 (1), p.105

2019

Volltextzugriff (PDF)

Revisiting NO2 as Protecting Group of Arginine in Solid-Phase Peptide Synthesis

International journal of molecular sciences, 2020-06, Vol.21 (12), p.4464

2020

Volltextzugriff (PDF)

Immune Response and Partial Protection against Heterologous Foot-and-Mouth Disease Virus Induced by Dendrimer Peptides in Cattle

Journal of Immunology Research, 2018-01, Vol.2018 (2018), p.1-12

2018

Volltextzugriff (PDF)

1 – 25 von 312

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(289)
Mit Volltextzugriff
(296)

Publikationsform

Artikel
(309)
Tagungsberichte
(3)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(249)
Physical Sciences
(143)
Chemistry
(141)
Life Sciences & Biomedicine
(139)
Peptides
(93)
Chemistry, Multidisciplinary
(69)
Biochemistry & Molecular Biology
(68)
Chemistry, Organic
(57)
Pharmacology & Pharmacy
(52)
Humans
(51)
Amino Acids
(44)
Chemistry, Medicinal
(39)
Solid-Phase Peptide Synthesis
(38)
Proteins
(33)
Amino Acid Sequence
(27)
Animals
(27)
Peptides - Chemistry
(27)
Review
(25)
Science & Technology - Other Topics
(24)
Drugs
(23)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

The Pharmaceutical Industry in 2018. An Analysis of FDA Drug Approvals from the Perspective of Molecules

The Pharmaceutical Industry in 2022: An Analysis of FDA Drug Approvals from the Perspective of Molecules

The Pharmaceutical Industry in 2019. An Analysis of FDA Drug Approvals from the Perspective of Molecules

The Pharmaceutical Industry in 2021. An Analysis of FDA Drug Approvals from the Perspective of Molecules

Peptide Therapeutics 2.0

Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate

The Pharmaceutical Industry in 2023: An Analysis of FDA Drug Approvals from the Perspective of Molecules

Breaking a Couple: Disulfide Reducing Agents

The Pharmaceutical Industry in 2017. An Analysis of FDA Drug Approvals from the Perspective of Molecules

The challenge of peptide nucleic acid synthesis

2021 FDA TIDES (Peptides and Oligonucleotides) Harvest

Safety-Catch Linkers for Solid-Phase Peptide Synthesis

Naturally Occurring Oxazole-Containing Peptides

2022 FDA TIDES (Peptides and Oligonucleotides) Harvest

2023 FDA TIDES (Peptides and Oligonucleotides) Harvest

The Pharmaceutical Industry in 2020. An Analysis of FDA Drug Approvals from the Perspective of Molecules

Scope and Limitations of γ-Valerolactone (GVL) as a Green Solvent to be Used with Base for Fmoc Removal in Solid Phase Peptide Synthesis

Serinol-Based Versatile Disulfide-Reducing Reagent

2018 FDA Tides Harvest

2017 FDA Peptide Harvest

1,3,5-Triazine as Branching Connector for the Construction of Novel Antimicrobial Peptide Dendrimers: Synthesis and Biological Characterization

Greening Fmoc/tBu solid-phase peptide synthesis

Synthesis and Antimicrobial Activity of a New Series of Thiazolidine-2,4-diones Carboxamide and Amino Acid Derivatives

Revisiting NO2 as Protecting Group of Arginine in Solid-Phase Peptide Synthesis

Immune Response and Partial Protection against Heterologous Foot-and-Mouth Disease Virus Induced by Dendrimer Peptides in Cattle

Suchergebnisse filtern